glp-1 and gip receptor agonist & Agonists | Obesity Diabetes Management | Harrison's updates (22nd Ed.) New strategies for the treatment
Description
GIPR adipo/ mice showed significant reductions in interleukin-6 (IL-6) mRNA expression in adipocytes, blood IL-6 levels, triglyceride accumulation in the liver, and systemic insulin resistance [104]
Alogliptin: Monitor renal function periodically.
A pooled analysis of CVOTs showing that therapy with GLP-1 RA does not increase the risk of acute pancreatitis or pancreatic cancer
PLoS ONE 10 , e0130894 (2015)
Mechanisms controlling glucose-induced GLP-1 secretion in human small intestine
That meant no dangerous sugar crashes, a common problem with some older diabetes drugs
